Bioforce Nanosciences Holdings (BFNH) Shares Outstanding (Diluted Average) (2021 - 2026)

Bioforce Nanosciences Holdings has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $33.5 million for Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 3.95% year-over-year to $33.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.5 million (up 3.95% YoY) and the FY2025 annual result came in at $33.2 million, up 13.45% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $33.5 million in Q1 2026, from $33.2 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $33.5 million in Q3 2025 and troughed at $29.3 million in Q2 2022.
• A 5-year average of $30.5 million and a median of $29.3 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) changed 0.0% — and 2025, when it increased 14.52%.
• Tracing BFNH's Shares Outstanding (Diluted Average) over 5 years: stood at $29.3 million in 2022, then changed by 0.0% to $29.3 million in 2023, then changed by 0.0% to $29.3 million in 2024, then gained by 13.45% to $33.2 million in 2025, then gained by 0.95% to $33.5 million in 2026.
• Business Quant data shows BFNH's Shares Outstanding (Diluted Average) at $33.5 million in Q1 2026, $33.2 million in Q4 2025, and $33.5 million in Q3 2025.